Driving Photodynamic Therapy Market Growth in 2025: The Role of Rising Prevalence Of Skin Cancer Drives Growth In The Photodynamic Therapy Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Photodynamic Therapy Market Size Growth Forecast: What to Expect by 2025?
Growth within the photodynamic therapy market size has seen a robust increase in recent years. The market size is predicted to rise from $1.45 billion in 2024 to $1.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this historical period increase include the surge in the aging population, a rise in cancer cases, an uptick in skin ailments, escalating pollution levels, amplified healthcare spending, and an expansion in the count of healthcare facilities.

How Will the Photodynamic Therapy Market Size Evolve and Grow by 2029?
Expectations are high for the photodynamic therapy market to witness robust expansion in the coming years, reaching $1.93 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%. This growth through the forecast period can be credited to the escalating healthcare spending, extended insurance coverage for photodynamic therapy, untapped potential in developing economies, growing adolescent and elderly populations, the rising prevalence of cancer and chronic ailments, and the appearance of new infectious diseases. Noteworthy trends expected to dominate the forecast period are the release of a portable photodynamic therapy device facilitating at-home dermatological PDT treatments, investment in AI-driven PDT for enhanced patient care, broadening the range of products used in cosmetic procedures, persistent investment in research and development, and efforts directed towards providing photoimmunotherapy devices and enlarging the portfolio to incorporate photothermal therapy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

What Drivers Are Propelling the Growth of Photodynamic Therapy Market Forward?
The escalating occurrence of skin cancer is bolstering the expansion of the photodynamic therapy market. Skin cancer ranks as the most widespread cancer among all the other types. Even though melanoma accounts for around 1% of skin cancer types, it results in a significant number of deaths related to skin cancer. Photodynamic therapy (PDT) efficiently uses a blend of light-sensitizing drugs and intensified light to annihilate cancer cells. A chemical solution that sensitizes light is applied by the doctor on the area affected by skin cancer and its surroundings. For instance, in January 2024, the American Cancer Society, a professional organization based in the U.S., reported that skin cancer is most rampant in the U.S, with melanoma making up around 1% of the cases but causing most deaths due to skincare. Additionally, in 2024, a projected 100,640 new melanoma cases are expected to be diagnosed in the U.S, with approximately 59,170 in men and 41,470 in women. Nearly 8,290 melanoma-linked deaths are predicted, which includes about 5,430 men and 2,860 women. Hence, the increasing rate of skin cancer is anticipated to spur the photodynamic therapy market's growth in the forthcoming years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Trends Will Shape the Photodynamic Therapy Market Through 2029 and Beyond?
Photodynamic therapy market participants are sharpening their focus on clinical trials that combine PDT with various medications. For example, Kintara Therapeutics, an American biotech firm, kicked off a clinical trial for its REM-001 treatment aimed at cutaneous metastatic breast cancer in February 2024. This open-label study, codenamed NCT05374915, encompasses 15 CMBC patients and tests the efficacy of the second-generation photodynamic therapy agent REM-001, administered at a dosage of 0.8 mg. The purpose of this trial is to streamline the study design before a Phase 3 trial and concentrate on the Best Overall Objective Response Rate (bORR) in treatment fields over a 24-week period. Primary endpoint focuses on the measurement of complete and partial responses.

What Are the Key Segments in the Photodynamic Therapy Market?
The photodynamic therapy market covered in this report is segmented -

1) By Product: Drugs, Devices
2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:
1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations
2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Who Are the Key Players Shaping the Photodynamic Therapy Market's Competitive Landscape?
Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

What Geographic Markets Are Powering Growth in the Photodynamic Therapy Market?
North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.